跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,573 条关于
“Biofrontera Pharma GmbH”
全部
10,573
临床试验
4,121
药物
1,206
机构
1,894
资讯
3,352
8个月前
Patent Disputes Highlight Innovation Challenges in Photodynamic Therapy and Genomic Sequencing Technologies
去年
FDA Decisions Loom for Biofrontera, BMS, and Zealand Pharma
去年
Biofrontera Inc. Negotiates Strategic Partnership Changes with German Parent Company
去年
Biofrontera Acquires Full US Rights to Ameluz and RhodoLED, Secures $11M Funding
11个月前
Biofrontera Inc. Completes $11M Asset Acquisition of Ameluz and RhodoLED US Rights
去年
TQ Therapeutics Acquires Juno GmbH to Advance Decentralized Cell Therapy Platform
6个月前
AveThera GmbH Acquires Fraunhofer ITEM Braunschweig Site to Expand Biopharmaceutical Manufacturing
去年
Biofrontera Completes Phase 2b Trial of Ameluz for Moderate to Severe Acne Treatment
去年
Biofrontera's Ameluz Secures Patent Extension to 2043, Targets $5.7B Acne Market
去年
Biofrontera Announces Database Lock for Phase 3 sBCC Study of Ameluz®-PDT
第 1 页,共 336 页
上一页
下一页